Moderna, Merck breakthrough could usher in wave of cancer vaccines
· economictimes.indiatimes.com
Merck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target specific tumor mutations. The vaccine, combined with Keytruda, significantly reduced cancer recurrence in trials. Doctors are hopeful this approach will expand to treat many other cancer types. Further trials are underway for lung, bladder, kidney, pancreatic, and stomach cancers.
MORE TRIALS TARGET OTHER CANCERS
Live Events
HOW IT WORKS
as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now!
(You can...